| Filed | Form | Description | |
|---|---|---|---|
| 3/25/25 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | → |
| 3/25/25 | DEF 14A | DEFINITIVE PROXY STATEMENT | → |
| 3/22/24 | DEFA14A | AMNEAL PHARMACEUTICALS, INC. - DEFA14A | → |
| 3/22/24 | DEF 14A | AMNEAL PHARMACEUTICALS, INC. - DEF 14A | → |
| 3/24/23 | DEFA14A | AMNEAL PHARMACEUTICALS, INC. - DEFA14A | → |
| 3/24/23 | DEF 14A | AMNEAL PHARMACEUTICALS, INC. - DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| 3/5/26 | 4 | 4 | → |
| ↓ | |||
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products.